Dianthus Therapeutics (DNTH) Amortization - Intangibles (2024 - 2025)

Dianthus Therapeutics (DNTH) recorded quarterly Amortization - Intangibles of $2.3 million in Q3 2025, up 110.47% quarter-over-quarter from $1.1 million in Q2 2025, and down 1.28% on a YoY basis from $2.3 million in Q3 2024.

Dianthus Therapeutics (DNTH) Amortization - Intangibles (2024 - 2025) Analysis & Trends

Dianthus Therapeutics' Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $2.3 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Dianthus Therapeutics 3.60 Bn 3.19 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 2.31 Mn
Jun 30, 2025 1.10 Mn
Mar 31, 2025 1.90 Mn
Sep 30, 2024 2.34 Mn
Jun 30, 2024 422,000.00
Mar 31, 2024 518,000.00